# IOVANCE BIOTHERAPEUTICS, INC. (IOVA) FY2026 Q2 Statement of Cash Flows

- Company: IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001104659-26-091716
- Page: https://plicit.ai/financials/iova/fy2026-q2-cash-flow
- Chart image: https://plicit.ai/charts/iova-fy2026-q2-cash-flow-sankey.png

## Chart details

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Mar 31, 2026**: 202,500,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- **Operating activities**: negative 60,841,000 US dollars. Net cash used.
- **Net Loss**: negative 47,315,000 US dollars
- **Depreciation and amortization of property and equipment**: 3,784,000 US dollars
- **Excess and obsolescence reserve**: 3,314,000 US dollars
- **Deferred tax benefit**: negative 1,373,000 US dollars
- **Unrealized foreign exchange loss (gain)**: 3,000 US dollars
- **Amortization of intangible assets**: 5,716,000 US dollars
- **Loss on asset disposals**: 642,000 US dollars
- **Gain on loan forgiveness**: negative 1,000,000 US dollars
- **Accretion of discounts and premiums on investments**: negative 1,413,000 US dollars
- **Operating lease liabilities**: negative 773,000 US dollars
- **Prepaid expenses, other assets and long-term assets**: 5,910,000 US dollars
- **Trade accounts receivable**: negative 20,361,000 US dollars
- **Inventory**: negative 177,000 US dollars
- **Accounts payable**: negative 11,818,000 US dollars
- **Accrued expenses and other liabilities**: negative 8,615,000 US dollars
- **Stock-based compensation expense**: 11,733,000 US dollars
- **Amortization of right of use asset**: 902,000 US dollars
- **Investing activities**: negative 74,050,000 US dollars. Net cash used.
- **Maturities of investments**: 61,000,000 US dollars
- **Purchase of investments**: negative 129,609,000 US dollars
- **Purchase of property and equipment**: negative 5,441,000 US dollars
- **Financing activities**: 49,288,000 US dollars. Net cash provided.
- **Tax payments related to shares withheld for vested restricted stock units**: negative 1,166,000 US dollars
- **Proceeds from the issuance of common stock under employee stock purchase plan**: 861,000 US dollars
- **Proceeds from the issuance of common stock upon exercise of options**: 26,000 US dollars
- **Proceeds from the issuance of common stock, net**: 49,567,000 US dollars
- **Operating adjustment reconciliation**: 92,845,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing gross reconciliation**: 50,454,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing gross reconciliation**: 135,050,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **Exchange-rate effect**: negative 124,000 US dollars
- **Ending cash on Jun 30, 2026**: 116,773,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- **Cash sources and uses**: 251,788,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: negative 85,727,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
- **Operating cash flow**: negative 60,841,000 US dollars. Operating cash flow used in the free cash flow calculation.
- **Cash purchases of property, plant and equipment**: 5,441,000 US dollars. These cash purchases are already included in investing activities above.
- **Free cash flow**: negative 66,282,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$47.32M − net operating adjustments $13.53M = operating cash −$60.84M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 60,841,000 US dollars minus 5,441,000 US dollars equals negative 66,282,000 US dollars.